REG - Futura Medical PLC - TR-1: Notification of major holdings
RNS Number : 8669WFutura Medical PLC28 April 2021TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0033278473
Issuer Name
FUTURA MEDICAL PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
HT Riverwood Multi-Growth Fund
City of registered office (if applicable)
George Town
Country of registered office (if applicable)
Cayman Islands
4. Details of the shareholder
Is the shareholder the same as the person subject to the notification obligation, above?
Yes
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
21-Apr-2021
6. Date on which Issuer notified
21-Apr-2021
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A)
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached
3.102000
0.000000
3.102000
7940000
Position of previous notification (if applicable)
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)
Number of direct voting rights (DTR5.1)
Number of indirect voting rights (DTR5.2.1)
% of direct voting rights (DTR5.1)
% of indirect voting rights (DTR5.2.1)
GB0033278473
7940000
3.102000
Sub Total 8.A
7940000
3.102000%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument
Expiration date
Exercise/conversion period
Number of voting rights that may be acquired if the instrument is exercised/converted
% of voting rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument
Expiration date
Exercise/conversion period
Physical or cash settlement
Number of voting rights
% of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling person
Name of controlled undertaking
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
HT Riverwood Multi-Growth Fund
HT Riverwood Multi-Growth Fund
3.102000
3.102000
10. In case of proxy voting
Is there proxy voting?
No
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
N/A
12. Date of Completion
27-Apr-2021
13. Place Of Completion
Hong Kong
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDHOLFIFFTSDITFIL
Recent news on Futura Medical
See all newsREG - Futura Medical PLC - Results for the Year ended 31 December 2023
AnnouncementREG - Futura Medical PLC - Notice of Results and Investor Presentation
AnnouncementRCS - Futura Medical PLC - Eroxon to be available on prescription
AnnouncementREG - Futura Medical PLC - Trading Update
AnnouncementREG - Futura Medical PLC - Appointment of Joint Corporate Broker
Announcement